A global study finds that walking 7,000 steps daily can significantly reduce the risk of death by heart disease, diabetes, dementia and more, offering a practical alternative to the 10,000-step target
Interchangeable biosimilar to NovoLog in the US and will be available in prefilled pens and vials
From blood pressure to mental health, these essential screenings help men detect silent health risks early and stay ahead of preventable chronic conditions
Indian astronaut Shubhanshu Shukla is leading muscle loss, diabetes, brain activity, and cancer cell studies on the ISS-research that could benefit both space explorers and patients on Earth
Fact-Check Friday: From the belief that fruits are bad to blaming sugar alone, doctors bust 15 widespread diabetes myths and offer clear, science-backed facts for better care
Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly
Despite common misconceptions, gestational diabetes can affect healthy women of any age or body type. Often symptomless, it frequently goes undiagnosed-putting both mother and child at risk
A 14-year study of nearly 3 million people found that emotional strain in public-facing roles may increase type 2 diabetes risk by up to 47 per cent
A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope for long-term freedom from injections
Abbott to distribute MSD's sitagliptin portfolio-Januvia, Janumet, Janumet XR-in India, targeting deeper reach in the ₹950-1,000 crore diabetes drug segment
Think juice is better than soda? A large new study shows even 100% fruit juice raises diabetes risk, urging people to eat whole fruits instead
The study, published in the Obesity Journal, examined the effects of anti-obesity injectables on weight reduction and blood sugar regulation (glycaemic control) in a real-world setting
It logged value sales worth Rs 12.61 crore in May, compared to Rs 7.88 crore in April.
The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus in adults, adolescents and children aged 10 years and above
Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market
Research shows that light walking for 2 minutes after every 20 minutes of sitting may significantly lower post-meal blood sugar levels
Achieving 15 per cent year-on-year growth, with nearly four biosimilars with $200 million in revenue, is a big feat, says Tambe
Despite the rise of GLP-1s and oral therapies, insulin remains vital for millions, particularly those with type 1 diabetes and other insulin-dependent conditions
Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions